Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Raised by J. Safra Sarasin Holding AG

J. Safra Sarasin Holding AG raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 66.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,409 shares of the medical equipment provider's stock after buying an additional 4,168 shares during the quarter. J. Safra Sarasin Holding AG's holdings in Intuitive Surgical were worth $5,433,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Howard Capital Management Group LLC boosted its holdings in shares of Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock valued at $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock valued at $295,938,000 after acquiring an additional 9,194 shares during the last quarter. World Investment Advisors LLC purchased a new stake in Intuitive Surgical during the third quarter valued at about $228,000. Arvest Bank Trust Division acquired a new stake in Intuitive Surgical during the third quarter worth about $260,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider's stock worth $272,980,000 after purchasing an additional 552,058 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on ISRG. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a research report on Monday, April 14th. Leerink Partners raised their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research report on Wednesday. Finally, Royal Bank of Canada reduced their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research report on Wednesday. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $598.95.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock traded up $6.46 during trading hours on Friday, reaching $514.59. The company's stock had a trading volume of 2,015,889 shares, compared to its average volume of 1,612,864. Intuitive Surgical, Inc. has a one year low of $367.39 and a one year high of $616.00. The company's 50 day simple moving average is $513.65 and its 200 day simple moving average is $532.19. The stock has a market cap of $183.29 billion, a P/E ratio of 80.28, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the business posted $1.50 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.